Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation.
Echocardiography has emerged as a fundamental tool in the evaluation of patients with atrial fibrillation (AF). Transthoracic echocardiography remains a primary tool for the evaluation and management of many patients presenting with their first episode of AF, but it is not adequate for exclusion of atrial thrombi. TEE offers excellent visualization of the atria and accurate identification or exclusion of thrombi. In concert with therapeutic anticoagulation, a TEE-guided approach to early cardioversion appears to have a safety profile similar to that of conventional therapy (1 month of precardioversion warfarin). The TEE-guided approach offers the advantages of simplified anticoagulation management and shorter duration of sustained AF, thereby allowing for a more rapid recovery of atrial mechanical function. Warfarin should be continued for 1 month after cardioversion to allow for more complete recovery of atrial function and for prophylaxis should the patient revert to AF. Cost-effectiveness models demonstrate that TEE-guided cardioversion represents a cost-effective strategy, but only if the transthoracic echocardiogram is omitted. For patients with a thrombus on the initial TEE, follow-up TEE (to document thrombus resolution) is recommended before cardioversion.
Cardiology Division, John Dempsey Hospital and University of Connecticut Health Center, Farmington, USA.
D I
DI
Silverman
W J
WJ
Manning
D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000000981:diagnostic imaging* / Q000628:therapy*; D004452:Echocardiography / Q000379:methods; D004554:Electric Countershock; D006801:Humans; D012307:Risk Factors; D013997:Time Factors; D018084:Ultrasonography, Interventional / Q000379:methods; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin